Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One option highlighted by a study in Taiwan showed that the implementation of financial incentives for health-care providers to deliver integrated care to those younger than 40 years with type 2 diabetes resulted in improved cardiovascular outcomes and mortality over 15 years of follow-up.47”
From Managing early-onset type 2 diabetes in the individual and at the population level (2025) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type 2 diabetes in adolescents and young adults
Lascar, N., Brown, J., Pattison, H., Barnett, A. H., Bailey, C. J., & Bellary, S. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30186-9 · Cited by 824
The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A.-M., Rosengren, A., McGuire, D. K., Eliasson, B., & Gudbjörnsdottir, S. (2019) · Circulation · doi:10.1161/circulationaha.118.037885 · Cited by 555
Yeung, R. O., Zhang, Y., Luk, A., Yang, W., Sobrepena, L., Yoon, K.-H., Aravind, S. R., Sheu, W., Nguyen, T. K., Ozaki, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70137-8 · Cited by 296
Evaluation of the Cascade of Diabetes Care in the United States, 2005-2016
Kazemian, P., Shebl, F. M., McCann, N., Walensky, R. P., & Wexler, D. J. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2396 · Cited by 252
Research works printed but not linked: 24
- 1975, to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults, Lancet, 2017, 2627
- Wu, 2021, Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study, Diabetologia, 64, 1990, 10.1007/s00125-021-05494-4 · DOI
- Currie, 2012, The impact of treatment noncompliance on mortality in people with type 2 diabetes, Diabetes Care, 35, 1279, 10.2337/dc11-1277 · DOI · Paper page
- Epstein, 2004, Paying physicians for high-quality care, N Engl J Med, 350, 406, 10.1056/NEJMsb035374 · DOI · Paper page
- Campbell, 2009, Effects of pay for performance on the quality of primary care in England, N Engl J Med, 361, 368, 10.1056/NEJMsa0807651 · DOI · Paper page
- Wang, 2014, Team care of type 2 diabetes mellitus in Taiwan, Diabetes Res Clin Pract, 106, S309, 10.1016/S0168-8227(14)70735-1 · DOI
- Mendelson, 2017, The effects of pay-for-performance programs on health, health care use, and processes of care: a systematic review, Ann Intern Med, 166, 341, 10.7326/M16-1881 · DOI · Paper page
- Gabel, 2019, An evaluation of a multifaceted, local quality improvement framework for long-term conditions in UK primary care, Fam Pract, 36, 607, 10.1093/fampra/cmy128 · DOI
- Hsieh, 2016, The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: a nationwide population-based cohort study, Prev Med, 85, 53, 10.1016/j.ypmed.2015.12.013 · DOI
- Kao, 2021, Importance of medication adherence in treatment needed diabetic retinopathy, Sci Rep, 11, 19100, 10.1038/s41598-021-98488-6 · DOI
- Sutton, 2012, Reduced mortality with hospital pay for performance in England, N Engl J Med, 367, 1821, 10.1056/NEJMsa1114951 · DOI · Paper page
- Hsieh, 2017, A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan, Int J Qual Health Care, 29, 512, 10.1093/intqhc/mzx057 · DOI
- Yen, 2021, Outcomes of second-line oral antidiabetic drugs in persons with young-onset type 2 diabetes, Diabetes Res Clin Pract, 177, 10.1016/j.diabres.2021.108928 · DOI
- Lin, 2005, Accuracy of diabetes diagnosis in health insurance claims data in Taiwan, J Formos Med Assoc, 104, 157
- Meduru, 2007, Chronic illness with complexity: implications for performance measurement of optimal glycemic control, J Gen Intern Med, 22, 408, 10.1007/s11606-007-0310-5 · DOI · Paper page
- Young, 2008, Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization, Am J Manag Care, 14, 15
- Petersen, 2017, Impact of a Pay-for-Performance program on care for black patients with hypertension: important answers in the era of the affordable care act, Health Serv Res, 52, 1138, 10.1111/1475-6773.12517 · DOI
- Glickman, 2007, Pay for performance, quality of care, and outcomes in acute myocardial infarction, JAMA, 297, 2373, 10.1001/jama.297.21.2373 · DOI · Paper page
- Lim, 2018, Aspects of multicomponent integrated care promote sustained improvement in surrogate clinical outcomes: a systematic review and meta-analysis, Diabetes Care, 41, 1312, 10.2337/dc17-2010 · DOI · Paper page
- Chiou, 2021, Synergy between the pay-for-performance scheme and better physician-patient relationship might reduce the risk of retinopathy in patients with type 2 diabetes, J Diabetes Investig, 12, 819, 10.1111/jdi.13422 · DOI
- Hsieh, 2007, Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients, Nephrol Dial Transplant, 32, 1184, 10.1093/ndt/gfw372 · DOI
- Sheen YJ, Kung PT, Kuo WY, Chiu LT, Tsai WC. Impact of the pay-for-performance program on lower extremity amputations in patients with diabetes in Taiwan. Medicine (Baltimore) 2018;97:e12759. 10.1097%2FMD.0000000000012759. · DOI
- Lee, 2019, Pay-for-performance for shared care of diabetes in Taiwan, J Formos Med Assoc, 118, S122, 10.1016/j.jfma.2019.08.011 · DOI
- Kristensen, 2014, Long-term effect of hospital pay for performance on mortality in England, N Engl J Med, 371, 540, 10.1056/NEJMoa1400962 · DOI
Cited by
Managing early-onset type 2 diabetes in the individual and at the population level
Misra, S., Khunti, K., Goyal, A., Gable, D., Armocida, B., Tandon, N., Sachdev, P., Wild, S. H., Hivert, M.-F., & Beran, D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01067-0 · Cited by 47
Lin, D. S., Lo, H., Huang, K., Lin, T., Lee, J., & Lin, L. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15788 · Cited by 16
Metadata
- Authors
- Yen, F.-S., Cheng-Chung Wei, J., Hung, Y.-T., Hsu, C.-C., & Hwu, C.-M.
- Venue
- Diabetes Research and Clinical Practice
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 193
- Pages
- 110136
- ISSN
- 0168-8227
- Cited by
- 11
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- China Medical University Hospital (DMR-111\u2013105)
- Taipei Veterans General Hospital (V105C-204, V110C-175, 110\u20132314-B-075\u2013027-MY3)
- Ministry of Science and Technology, Taiwan (110\u20132321-B-039\u2013005)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes. https://app.cochat.ai/papers/10.1016/j.diabres.2022.110136
- The paper
- Yen, F.-S., Cheng-Chung Wei, J., Hung, Y.-T., Hsu, C.-C., & Hwu, C.-M. (2022). Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2022.110136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.